Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Chemours (CC) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Chemours (CC) over the last 12 years, with Q3 2025 value amounting to $16.0 million.

  • Chemours' Non Operating Income rose 16666.67% to $16.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.0 million, marking a year-over-year increase of 200000.0%. This contributed to the annual value of $8.0 million for FY2024, which is 9120.88% down from last year.
  • Latest data reveals that Chemours reported Non Operating Income of $16.0 million as of Q3 2025, which was up 16666.67% from $2.0 million recorded in Q2 2025.
  • In the past 5 years, Chemours' Non Operating Income registered a high of $132.0 million during Q4 2021, and its lowest value of -$31.0 million during Q4 2022.
  • For the 5-year period, Chemours' Non Operating Income averaged around $18.8 million, with its median value being $5.0 million (2024).
  • Its Non Operating Income has fluctuated over the past 5 years, first skyrocketed by 57142.86% in 2021, then crashed by 12348.48% in 2022.
  • Quarter analysis of 5 years shows Chemours' Non Operating Income stood at $132.0 million in 2021, then crashed by 123.48% to -$31.0 million in 2022, then surged by 70.97% to -$9.0 million in 2023, then soared by 77.78% to -$2.0 million in 2024, then skyrocketed by 900.0% to $16.0 million in 2025.
  • Its Non Operating Income stands at $16.0 million for Q3 2025, versus $2.0 million for Q2 2025 and $5.0 million for Q1 2025.